Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Gennarelli

Showing results (101-110 of 213) with videos related to

Pageof 22
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 18, 2023
Biological markers of sex-based differences in major depressive disorder and in antidepressant responseRosana Carvalho Silva, Claudia Pisanu, Elisabetta Maffioletti, et al.
Neuroreport|January 11, 2005
Antidepressants activate CaMKII in neuron cell body by Thr286 phosphorylationEttore Tiraboschi, Roberto Giambelli, Giordano D'Urso, et al.
Neuroimmunomodulation|November 20, 2009
The MCP-1 gene (SCYA2) and mood disorders: preliminary results of a case-control association studyA Carlo Altamura, Emanuela Mundo, Elisabetta Cattaneo, et al.
Drug Development Research|March 17, 2020
Genetic determinants of circulating VEGF levels in major depressive disorder and electroconvulsive therapy responseElisabetta Maffioletti, Massimo Gennarelli, Chiara Magri, et al.
Alzheimer'S Research & Therapy|November 18, 2020
Genetic counselling and testing for inherited dementia: single-centre evaluation of the consensus Italian DIAfN protocolAnna Mega, Samantha Galluzzi, Cristian Bonvicini, et al.
Neuroscience Letters|March 18, 2008
Effect of the XbaI polymorphism of estrogen receptor alpha on postmenopausal gray matterMarina Boccardi, Catia Scassellati, Roberta Ghidoni, et al.
Early Intervention in Psychiatry|November 22, 2019
Correlations between immune and metabolic serum markers and schizophrenia/bipolar disorder polygenic risk score in first-episode psychosisCarlo Maj, Sarah Tosato, Roberta Zanardini, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|May 26, 2022
Genome-wide association studies on Northern Italy isolated populations provide further support concerning genetic susceptibility for major depressive disorderVincenzo Dattilo, Sheila Ulivi, Alessandra Minelli, et al.
Clinical Epigenetics|July 17, 2024
Unraveling epigenomic signatures and effectiveness of electroconvulsive therapy in treatment-resistant depression patients: a prospective longitudinal studyRosana Carvalho Silva, Paolo Martini, Christa Hohoff, et al.
Psychiatry Research|December 24, 2014
The role of the potassium channel gene KCNK2 in major depressive disorderChiara Congiu, Alessandra Minelli, Cristian Bonvicini, et al.
Pageof 22

Showing results (101-110 of 213) with videos related to

Sort By:
Pageof 22
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 18, 2023
Biological markers of sex-based differences in major depressive disorder and in antidepressant responseRosana Carvalho Silva, Claudia Pisanu, Elisabetta Maffioletti, et al.
Neuroreport|January 11, 2005
Antidepressants activate CaMKII in neuron cell body by Thr286 phosphorylationEttore Tiraboschi, Roberto Giambelli, Giordano D'Urso, et al.
Neuroimmunomodulation|November 20, 2009
The MCP-1 gene (SCYA2) and mood disorders: preliminary results of a case-control association studyA Carlo Altamura, Emanuela Mundo, Elisabetta Cattaneo, et al.
Drug Development Research|March 17, 2020
Genetic determinants of circulating VEGF levels in major depressive disorder and electroconvulsive therapy responseElisabetta Maffioletti, Massimo Gennarelli, Chiara Magri, et al.
Alzheimer'S Research & Therapy|November 18, 2020
Genetic counselling and testing for inherited dementia: single-centre evaluation of the consensus Italian DIAfN protocolAnna Mega, Samantha Galluzzi, Cristian Bonvicini, et al.
Neuroscience Letters|March 18, 2008
Effect of the XbaI polymorphism of estrogen receptor alpha on postmenopausal gray matterMarina Boccardi, Catia Scassellati, Roberta Ghidoni, et al.
Early Intervention in Psychiatry|November 22, 2019
Correlations between immune and metabolic serum markers and schizophrenia/bipolar disorder polygenic risk score in first-episode psychosisCarlo Maj, Sarah Tosato, Roberta Zanardini, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|May 26, 2022
Genome-wide association studies on Northern Italy isolated populations provide further support concerning genetic susceptibility for major depressive disorderVincenzo Dattilo, Sheila Ulivi, Alessandra Minelli, et al.
Clinical Epigenetics|July 17, 2024
Unraveling epigenomic signatures and effectiveness of electroconvulsive therapy in treatment-resistant depression patients: a prospective longitudinal studyRosana Carvalho Silva, Paolo Martini, Christa Hohoff, et al.
Psychiatry Research|December 24, 2014
The role of the potassium channel gene KCNK2 in major depressive disorderChiara Congiu, Alessandra Minelli, Cristian Bonvicini, et al.
Pageof 22